Related Experiment Video
Updated: Jun 14, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.0K
Enzalutamide in Men With High-Risk Biochemically Recurrent Prostate Cancer: Rationale and Treatment Considerations
Neal D Shore1, Ugo De Giorgi2, Stephen J Freedland3,4
1Carolina Urologic Research Center, Myrtle Beach, South Carolina.
The Journal of Urology
|September 3, 2024
Abstract
No abstract available in PubMed .

